Trevena Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 62

Employees

  • Stock Symbol
  • TRVN

Stock Symbol

Trevena General Information

Description

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Contact Information

Website
www.trevena.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 955 Chesterbrook Boulevard
  • Suite 110
  • Chesterbrook, PA 19087
  • United States
+1 (610)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 955 Chesterbrook Boulevard
  • Suite 110
  • Chesterbrook, PA 19087
  • United States
+1 (610)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trevena Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
1.05K

Trevena Financials Summary

As of 30-Sep-2024, Trevena has a trailing 12-month revenue of $628K.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 23,297 11,317 (9,283) 24,472
Revenue 628 3,125 (418) 567
EBITDA (31,889) (37,391) (52,483) (51,321)
Net Income (34,036) (40,289) (53,670) (51,588)
Total Assets 19,188 40,605 48,680 80,124
Total Debt 37,564 36,245 19,765 7,101
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Trevena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Trevena‘s full profile, request access.

Request a free trial

Trevena Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Trevena‘s full profile, request access.

Request a free trial

Trevena Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patie
Drug Discovery
Chesterbrook, PA
62 As of 2025

San Diego, CA
 

Coral Gables, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trevena Competitors (47)

One of Trevena’s 47 competitors is ACADIA Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
Catalyst Pharmaceuticals Corporate Backed or Acquired Coral Gables, FL
Kainova Therapeutics Venture Capital-Backed Montreal, Canada
Sio Gene Therapies Formerly VC-backed New York, NY
Incyte Formerly VC-backed Wilmington, DE
You’re viewing 5 of 47 competitors. Get the full list »

Trevena Patents

Trevena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023070605-A1 Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds Inactive 29-Oct-2021
WO-2023077049-A1 Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds Inactive 29-Oct-2021
US-20240025949-A1 Beta-arrestin effectors and compositions and methods of use thereof Inactive 30-Sep-2021
EP-4236939-A1 Crystalline and amorphous forms of a delta-opioid modulator Pending 27-Oct-2020
EP-4236939-A4 Crystalline and amorphous forms of a delta-opioid modulator Pending 27-Oct-2020 C07D401/14
To view Trevena’s complete patent history, request access »

Trevena Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trevena ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Trevena’s complete esg history, request access »

Trevena FAQs

  • When was Trevena founded?

    Trevena was founded in 2007.

  • Where is Trevena headquartered?

    Trevena is headquartered in Chesterbrook, PA.

  • What is the size of Trevena?

    Trevena has 62 total employees.

  • What industry is Trevena in?

    Trevena’s primary industry is Drug Discovery.

  • Is Trevena a private or public company?

    Trevena is a Public company.

  • What is Trevena’s stock symbol?

    The ticker symbol for Trevena is TRVN.

  • What is Trevena’s current revenue?

    The trailing twelve month revenue for Trevena is $628K.

  • Who are Trevena’s competitors?

    ACADIA Pharmaceuticals, Catalyst Pharmaceuticals, Kainova Therapeutics, Sio Gene Therapies, and Incyte are some of the 47 competitors of Trevena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process